Objectives - The aim of this study was to investigate the clinical efficacy of clozapine, an atypical neuroleptic, on L-dopa induced dyskinesias of Parkinson's disease. Material and methods - In an open study, a group of 10 PD patients was treated with low dosage clozapine (mean 30 mg/day) for a 4-month period and L-dopa dyskinesias were evaluated in basal conditions and during clozapine treatment after the usual morning dose of clozapine. We utilized the AIMS for evaluation of dyskinesias and UPDRS for the assessment of motor performances. Results - Clozapine produced a significant (P<0.05) reduction of dyskinesias 1 week after the therapy onset. This effect was more pronounced at the end of the 2nd week and remained stable through the following months. We did not observe significant variations of motor performances. Conclusion - A low dose of clozapine appears to be beneficial for patients with L-dopa induced dyskinesias that do not respond to other drugs and therapeutic measures.

Low dosage clozapine effects on L-dopa induced dyskinesias in parkinsonian patients / Pierelli, Francesco; A., Adipietro; Soldati, Giampiero; Fattapposta, Francesco; Pozzessere, Giuseppe; Scoppetta, Ciriaco. - In: ACTA NEUROLOGICA SCANDINAVICA. - ISSN 0001-6314. - STAMPA. - 97:5(1998), pp. 295-299. [10.1111/j.1600-0404.1998.tb05955.x]

Low dosage clozapine effects on L-dopa induced dyskinesias in parkinsonian patients

PIERELLI, Francesco;SOLDATI, Giampiero;FATTAPPOSTA, FRANCESCO;POZZESSERE, Giuseppe;SCOPPETTA, Ciriaco
1998

Abstract

Objectives - The aim of this study was to investigate the clinical efficacy of clozapine, an atypical neuroleptic, on L-dopa induced dyskinesias of Parkinson's disease. Material and methods - In an open study, a group of 10 PD patients was treated with low dosage clozapine (mean 30 mg/day) for a 4-month period and L-dopa dyskinesias were evaluated in basal conditions and during clozapine treatment after the usual morning dose of clozapine. We utilized the AIMS for evaluation of dyskinesias and UPDRS for the assessment of motor performances. Results - Clozapine produced a significant (P<0.05) reduction of dyskinesias 1 week after the therapy onset. This effect was more pronounced at the end of the 2nd week and remained stable through the following months. We did not observe significant variations of motor performances. Conclusion - A low dose of clozapine appears to be beneficial for patients with L-dopa induced dyskinesias that do not respond to other drugs and therapeutic measures.
1998
clozapine; dyskinesias; parkinson's disease
01 Pubblicazione su rivista::01a Articolo in rivista
Low dosage clozapine effects on L-dopa induced dyskinesias in parkinsonian patients / Pierelli, Francesco; A., Adipietro; Soldati, Giampiero; Fattapposta, Francesco; Pozzessere, Giuseppe; Scoppetta, Ciriaco. - In: ACTA NEUROLOGICA SCANDINAVICA. - ISSN 0001-6314. - STAMPA. - 97:5(1998), pp. 295-299. [10.1111/j.1600-0404.1998.tb05955.x]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/256707
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 37
social impact